Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense

NCT01425788 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
236
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ALK-Abelló A/S

Collaborators